Boston Scientific Corporation is scheduled to participate in the Morgan Stanley Global Healthcare Conference on September 14th in New York City.

NATICK, Mass., Aug. 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that results from studies involving the Company's Women's Health products will be presented at the Joint Annual Meeting of the International Continence Society (ICS) and International Urogynecological Association (IUGA). The presentations will feature Boston Scientific's pelvic floor ...

Boston Scientific Corporation today announced that results from studies involving the Company's Women's Health products will be presented at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association . � The presentations will feature Boston Scientific's pelvic floor reconstruction systems and mid-urethral sling systems. � The meeting will be ...

Boston Scientific Corporation (NYSE: BSX) announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGY Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia. The SYNERGY Stent uses a ...

Boston Scientific Corporation today announced that it has been notified by the U.S. Food and Drug Administration that all issues cited in the Company's corporate warning letter have been resolved. �